Surveillance of adverse events following immunisation in Australia, 2015 [0.03%]
2015年澳大利亚疫苗接种后不良事件监测报告
Aditi Dey,Han Wang,Helen Quinn et al.
Aditi Dey et al.
This report summarises Australian passive surveillance data for adverse events following immunisation (AEFI) for 2015 reported to the Therapeutic Goods Administration and compares them to long-term trends. There were 2,924 AEFI records for ...
Cindy Toms,Richard Stapledon,Chris Coulter et al.
Cindy Toms et al.
In 2014, the National Notifiable Diseases Surveillance System received 1,339 tuberculosis (TB) notifications, representing a rate of 5.7 per 100,000 population. Australia has achieved and maintained good tuberculosis (TB) control since the ...
Australian Meningococcal Surveillance Programme, 1 April to 30 June 2017 [0.03%]
2017年4月1日至6月30日澳大利亚脑膜炎球菌监测项目报告
Monica M Lahra,Rodney Enriquez
Monica M Lahra
The reference laboratories of the Australian Meningococcal Surveillance Programme (AMSP) report data on the number of cases of invasive meningococcal disease (IMD) confirmed by laboratory testing using culture and by non-culture based techn...
The epidemiology of tuberculosis in the Australia Capital Territory, 2006-2015 [0.03%]
2006-2015年澳大利亚首都地区结核病流行病学分析
Belinda J Jones,Vanessa Johnston,Ranil D Appuhamy et al.
Belinda J Jones et al.
Aim: To review the epidemiology of tuberculosis (TB) in the Australian Capital Territory (ACT) over a 10 year period. Methods: A retrospective analysis of the ACT TB notification data from 1 January 2006 to 31 December 20...
The effects of culture independent diagnostic testing on the diagnosis and reporting of enteric bacterial pathogens in Queensland, 2010 to 2014 [0.03%]
2010至2014年文化独立诊断检测对昆士兰肠道细菌病原体的诊断和报告的影响
Fiona J May,Russell J Stafford,Heidi Carroll et al.
Fiona J May et al.
Changes in diagnostic laboratory testing procedures can impact on the number of cases notified and the public health surveillance of enteric pathogens. Culture independent diagnostic testing using a multiplex polymerase chain reaction (PCR)...
Sexually Transmitted Infections in Melbourne, Australia from 1918 to 2016: nearly a century of data [0.03%]
1918至2016年的澳大利亚墨尔本性传播感染：近一个世纪的数据
Emile Jasek,Eric Pf Chow,Jason J Ong et al.
Emile Jasek et al.
Introduction: Our aim was to describe trends in the number of bacterial sexually transmitted infections (STIs) diagnosed at Melbourne's sexual health clinic over a century. ...
How much does tuberculosis cost? An Australian healthcare perspective analysis [0.03%]
结核病的经济负担有多少？基于澳大利亚卫生系统的分析视角
Eddie Chan,Aine Nolan,Justin Denholm
Eddie Chan
Tuberculosis (TB) remains a disease of high morbidity in Australia, with implications for both public health and the individual. Cost analyses is relevant for programmatic evaluation of TB. There is minimal published TB cost data in the Aus...
National position statement for the management of latent tuberculosis infection [0.03%]
潜伏性结核感染管理的国家立场文件
David Stock;National Tuberculosis Advisory Committee
David Stock;National Tuberculosis Advisory Committee
The primary role of any tuberculosis (TB) control program is to ensure the prompt identification and effective treatment of active disease. The host immune system often succeeds in containing the initial (or primary) infection with Mycobact...
National Tuberculosis Advisory Committee Guideline: Management of Tuberculosis Risk in Healthcare Workers in Australia [0.03%]
澳大利亚国家结核病咨询委员会指南：医务人员结核感染风险控制措施
Justin Waring,Justin Waring;National Tuberculosis Advisory Committee
Justin Waring
Tuberculosis (TB) is uncommon in Australia and not commonly managed by most healthcare workers (HCWs). However, even in a low incidence setting, occasional exposure of HCWs is inevitable and transmission of TB to HCWs leading to disease doe...
Practice Guideline
Communicable diseases intelligence quarterly report. 2017 Sep 1;41(3):E199-E203. DOI: 2017
Prevention of perinatal hepatitis B virus transmission: are we following guidelines? [0.03%]
乙型肝炎病毒宫内感染预防：我们在遵循指南吗？
Peter G Markey,Helena A White,Alexander T Matthews et al.
Peter G Markey et al.
It is recommended that infants born to women with hepatitis B infection should have serological review following completion of a four dose vaccination schedule. A review was undertaken on 102 neonates who received hepatitis B immunoglobulin...